Literature DB >> 11592300

Biological and clinical relevance of Laminin-5 in cancer.

G Giannelli1, S Antonaci.   

Abstract

The occurrence of metastases is the hallmark of cancer. Development of metastasis severely affects prognosis and survival. It limits or discourages therapeutic interventions since no therapies are available to block or prevent cancer invasion. In order to invade, epithelial cancer cells need to penetrate through the basement membrane (BM) and remove extra-cellular matrix (ECM) tissue boundaries. In this context, proteases play a key role since they can either degrade or process the ECM components and thereby support cancer cell invasion. Laminin-5 (Ln-5) is an ECM protein, expressed predominantly in the BM structure, that promotes static adhesion and hemidesmosome formation. However, it also stimulates cell migration and/or invasion after having been cleaved by matrix metalloproteinases (MMPs) such as MMP-2 and MT1-MMP. Based on its dual functions, it would be intriguing to elucidate the role that Ln-5 plays in cancer cell motility and metastasis. One possibility is that MMPs, secreted by cancer cells or by neighbouring stromal cells, can cleave the gamma2 chain of Ln-5 deposited along the advancing edge of tumors. Ln-5, and in particular its gamma2 chain, has been found to be preferentially expressed in the cytoplasm of epithelial human cancer cells located at the advancing edge of the tumor. Such a distribution, which is restricted only to malignancies, suggests that the gamma2 chain may be implicated in epithelial cancer growth and invasion. Although the clinical significance of this finding is not yet clear, it seems often to be associated with a more aggressive and invasive cancer phenotype. This article will review the current body of evidence implicating the Ln-5 molecule, and in particular its gamma2 chain, as an important player in the tumor cascade and progression to metastatic disease. This will then be followed by a discussion of the presented data and its limitations. Finally, suggestions will be provided to improve the current state of knowledge in the field and future implications will be briefly discussed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11592300     DOI: 10.1023/a:1011879900554

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  31 in total

1.  Regulated synthesis and functions of laminin 5 in polarized madin-darby canine kidney epithelial cells.

Authors:  Grace Z Mak; Gina M Kavanaugh; Mary M Buschmann; Shaun M Stickley; Manuel Koch; Kathleen Heppner Goss; Holly Waechter; Anna Zuk; Karl S Matlin
Journal:  Mol Biol Cell       Date:  2006-06-14       Impact factor: 4.138

2.  Novel genes implicated in embryonal, alveolar, and pleomorphic rhabdomyosarcoma: a cytogenetic and molecular analysis of primary tumors.

Authors:  Myriam Goldstein; Isaac Meller; Josephine Issakov; Avi Orr-Urtreger
Journal:  Neoplasia       Date:  2006-05       Impact factor: 5.715

Review 3.  Role of the tissue microenvironment as a therapeutic target in hepatocellular carcinoma.

Authors:  Bhavna Rani; Yuan Cao; Andrea Malfettone; Ciprian Tomuleasa; Isabel Fabregat; Gianluigi Giannelli
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

4.  Laminin 332 expression in breast carcinoma.

Authors:  Soon-Young Kwon; Seoung W Chae; Sharon P Wilczynski; Ahmad Arain
Journal:  Appl Immunohistochem Mol Morphol       Date:  2012-03

5.  MMP-10 is overexpressed, proteolytically active, and a potential target for therapeutic intervention in human lung carcinomas.

Authors:  Jason H Gill; Ian G Kirwan; Jill M Seargent; Sandie W Martin; Sidiq Tijani; Vladimir A Anikin; Alan J Mearns; Michael C Bibby; Alan Anthoney; Paul M Loadman
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

6.  Laminin-5 gamma2-chain expression and DNA ploidy as predictors of prognosis in endometrial carcinoma.

Authors:  C Lundgren; B Frankendal; C Silfverswärd; B Nilsson; K Tryggvason; G Auer; B Nordström
Journal:  Med Oncol       Date:  2003       Impact factor: 3.064

7.  The role of structural extracellular matrix proteins in urothelial bladder cancer (review).

Authors:  Andrea Brunner; Alexandar Tzankov
Journal:  Biomark Insights       Date:  2007-11-05

8.  Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2.

Authors:  Dirk Zboralski; Bettina Warscheid; Susanne Klein-Scory; M Bassel Malas; Heiko Becker; Miriam Böckmann; Helmut E Meyer; Wolff Schmiegel; Patricia Simon-Assmann; Irmgard Schwarte-Waldhoff
Journal:  Mol Cancer       Date:  2010-03-22       Impact factor: 27.401

9.  Transforming growth factor-beta1 triggers hepatocellular carcinoma invasiveness via alpha3beta1 integrin.

Authors:  Gianluigi Giannelli; Emilia Fransvea; Felice Marinosci; Carlo Bergamini; Silvia Colucci; Oronzo Schiraldi; Salvatore Antonaci
Journal:  Am J Pathol       Date:  2002-07       Impact factor: 4.307

10.  The biological relevance of laminin 5gamma2 expression at the invading edge of colonic carcinomas.

Authors:  Clase Lenander; Carlos A Rubio
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.